{"id":"https://openalex.org/W2181532991","doi":null,"title":"FORMULATION AND EVALUATION OF FINGOLIMOD CAPSULES Research Article","display_name":"FORMULATION AND EVALUATION OF FINGOLIMOD CAPSULES Research Article","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2181532991","mag":"2181532991"},"language":"en","primary_location":{"id":"mag:2181532991","doi":null,"is_oa":false,"landing_page_url":"http://www.ijppsjournal.com/Vol4Suppl1/3217.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055392776","display_name":"K. Kathiresan","orcid":"https://orcid.org/0000-0003-0338-0937","observed_orcids":["https://orcid.org/0000-0003-0338-0937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Kathiresan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054250029","display_name":"Micaela B. Reddy","orcid":"https://orcid.org/0000-0002-2721-3714","observed_orcids":["https://orcid.org/0000-0002-2721-3714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Micaela B. Reddy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2721-3714","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006603738","display_name":"Carolin Moorthi","orcid":"https://orcid.org/0000-0002-4925-2626","observed_orcids":["https://orcid.org/0000-0002-4925-2626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Moorthi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061101247","display_name":"Nannan Sha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nannan Sha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024287129","display_name":"Radhakrishnan Manavalan","orcid":"https://orcid.org/0000-0002-8683-4692","observed_orcids":["https://orcid.org/0000-0002-8683-4692"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Manavalan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8683-4692","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12000459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.6025000214576721,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.6025000214576721,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.18490000069141388,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.062199998646974564,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.824999988079071},{"id":"https://openalex.org/keywords/capsule-formulation","display_name":"capsule formulation","score":0.722000002861023},{"id":"https://openalex.org/keywords/generic-drug-formulation","display_name":"generic drug formulation","score":0.6100000143051147},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.6029999852180481},{"id":"https://openalex.org/keywords/stability-studies","display_name":"stability studies","score":0.6349999904632568},{"id":"https://openalex.org/keywords/drug-content-uniformity","display_name":"drug content uniformity","score":0.6230000257492065},{"id":"https://openalex.org/keywords/oral-drug-formulation","display_name":"oral drug formulation","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.9791750311851501},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7597566843032837},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.6352018713951111},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6108548045158386},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5776084661483765},{"id":"https://openalex.org/C2778778583","wikidata":"https://www.wikidata.org/wiki/Q147768","display_name":"Capsule","level":2,"score":0.4798438251018524},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46540123224258423},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.42986708879470825},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.14885759353637695},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09748387336730957},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.05656403303146362},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C34974158","wikidata":"https://www.wikidata.org/wiki/Q131257","display_name":"Intellectual property","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2181532991","doi":null,"is_oa":false,"landing_page_url":"http://www.ijppsjournal.com/Vol4Suppl1/3217.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2054368151","https://openalex.org/W2103925177","https://openalex.org/W2188833482","https://openalex.org/W2336195332","https://openalex.org/W2605102829"],"related_works":["https://openalex.org/W4395078448","https://openalex.org/W2319166677","https://openalex.org/W2118162032","https://openalex.org/W7162445679","https://openalex.org/W1963712903","https://openalex.org/W1716428631","https://openalex.org/W1553744964","https://openalex.org/W7096753153","https://openalex.org/W4387639078","https://openalex.org/W4409517060"],"abstract_inverted_index":{"Multiple":[0,61],"sclerosis":[1],"is":[2,16,28,39],"the":[3,10,17,29,35,44,50,53,71,89,99,119,167,180,183],"most":[4],"common":[5],"chronic":[6],"inflammatory":[7],"disease":[8],"of":[9,20,46,56,70,86,94,101,124,148,171,185],"central":[11],"nervous":[12],"system":[13],"and":[14,82,106,112,118,126,132,142,160],"it":[15],"leading":[18],"cause":[19],"neurological":[21],"disability":[22],"in":[23,49,154],"young":[24],"adults.":[25],"Fingolimod":[26,37,59,64,95,172],"Hydrochloride":[27,38,96,173],"first":[30],"oral":[31],"drug":[32,116,122,134,158],"approved":[33],"by":[34],"USFDA.":[36],"available":[40],"as":[41],"capsule":[42,168],"at":[43],"dose":[45,100],"0.5":[47,102],"mg":[48,103],"market":[51],"under":[52],"brand":[54],"name":[55],"Gilenya\u00ae":[57],"Keyword:":[58],"Hydrochloride,":[60],"sclerosis,":[62],"Pearlitol,":[63],"capsules":[65,97],".":[66],"The":[67,130],"primary":[68],"aim":[69],"study":[72,91,147],"was":[73,128,136],"to":[74,138],"develop":[75],"a":[76],"pharmaceutically":[77],"equivalent,":[78],"stable,":[79],"cost":[80],"effective":[81],"quality":[83],"improved":[84],"formulation":[85],"capsules.":[87],"In":[88],"present":[90],"five":[92],"batches":[93],"with":[98],"were":[104],"formulated":[105],"evaluated.":[107],"Formulation":[108],"F1,":[109],"F3,":[110],"F4":[111,127,149],"F5":[113],"demonstrated":[114,150],"better":[115],"release":[117,123],"percentage":[120],"cumulative":[121],"innovator":[125,181],"comparable.":[129],"maximum":[131],"minimum":[133],"content":[135,159],"found":[137],"be":[139,175],"100.50%":[140],"(F4)":[141,170],"67.10%":[143],"(F2)":[144],"respectively.":[145],"Stability":[146],"no":[151],"significant":[152],"changes":[153],"appearance,":[155],"water":[156],"content,":[157],"dissolution":[161],"profile":[162],"after":[163],"each":[164],"month.":[165],"Hence,":[166],"formulations":[169],"may":[174],"an":[176],"advantageous":[177],"alternative":[178],"for":[179,182],"treatment":[184],"multiple":[186],"sclerosis.":[187]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}